In contrast to pathogenic Th1 and Th17 responses, regulatory T cells (Tregs) were proven to be inhibitors of various effector T cells such as IFN-γ-producing Th1 cells and the recently identified IL-17+ T helper 17 (Th17) cells in GN [29]. This evidence concerns the gene IFNG and ganglioneuroma.